Yüklüyor......
Is Insurance a Barrier to HIV Preexposure Prophylaxis? Clarifying the Issue
Clinical trials have demonstrated that preexposure prophylaxis (PrEP) protects against HIV infection; yet, even with its approval by the Food and Drug Administration (FDA) in 2012, less than 10% of eligible users in the United States are currently taking PrEP. While there are multiple factors that i...
Kaydedildi:
| Yayımlandı: | Am J Public Health |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Public Health Association
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6893325/ https://ncbi.nlm.nih.gov/pubmed/31725314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2105/AJPH.2019.305389 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|